Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.37+0.03 (+0.47%)
Close on Nov 19, 2026Market cap $465.52MP/E –Yield –
Valneva shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 168M, up 15.4% from the year before. The highest annual figure on record is 168M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 168M | +15.4% |
| FY2024 | Dec 31, 2024 | 146M | +5.1% |
| FY2023 | Dec 31, 2023 | 139M | +20.0% |
| FY2022 | Dec 31, 2022 | 115M | +18.3% |
| FY2021 | Dec 31, 2021 | 98M | +7.6% |
| FY2020 | Dec 31, 2020 | 91M | -1.1% |
| FY2019 | Dec 31, 2019 | 92M | – |
See a number that looks wrong?